0 Ratings

ID

12674

Description

Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)

Keywords

  1. 3/4/15 3/4/15 -
  2. 3/9/15 3/9/15 -
  3. 4/23/15 4/23/15 -
  4. 12/9/15 12/9/15 -
  5. 2/11/16 2/11/16 -
Uploaded on

December 9, 2015

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Concomitant Medication AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

    Concomitant Medication AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

    Concomitant Medication
    Description

    Concomitant Medication

    Alias
    UMLS CUI-1
    C2347852 (Concomitant Agent)
    Point in time
    Description

    Point in time

    Data type

    integer

    Alias
    UMLS CUI [1,1]
    C1276413 (Therapeutic regimen)
    SNOMED
    133877004
    UMLS CUI [1,2]
    C2348792 (Timepoint)
    If Maintenance: Month
    Description

    Maintenance Month

    Data type

    integer

    Measurement units
    • Month
    Alias
    UMLS CUI [1,1]
    C0481504 (Maintenance Chemotherapy)
    UMLS CUI [1,2]
    C0439231 (month)
    SNOMED
    258706009
    Pharmalogical Substance
    Description

    Pharmalogical Substance

    Data type

    text

    Alias
    UMLS CUI [1]
    C0013227 (Pharmaceutical Preparations)
    SNOMED
    763158003
    LOINC
    LP100609-9
    Dose
    Description

    Dose

    Data type

    integer

    Alias
    UMLS CUI [1]
    C3174092 (Medication dose)
    LOINC
    LP116765-1
    Unit
    Description

    Unit

    Data type

    text

    Alias
    UMLS CUI-1
    C0869039 (Unit dose)
    SNOMED
    408102007
    Application
    Description

    Application

    Data type

    text

    Alias
    UMLS CUI [1]
    C0185125 (Application procedure)
    SNOMED
    410618006
    Frequency
    Description

    Frequency

    Data type

    text

    Alias
    UMLS CUI [1]
    C3476109 (Medication frequency)
    LOINC
    LP149758-7
    Medical indication
    Description

    Medical indication

    Data type

    text

    Alias
    UMLS CUI-1
    C2315323 (Indication for procedure)
    SNOMED
    432678004
    Start Date of Medication
    Description

    Start Date of Medication

    Data type

    date

    Alias
    UMLS CUI [1,1]
    C0013227 (Pharmaceutical Preparations)
    SNOMED
    763158003
    LOINC
    LP100609-9
    UMLS CUI [1,2]
    C0808070 (Start Date)
    Stop Date Medication
    Description

    Stop Date

    Data type

    date

    Alias
    UMLS CUI [1,1]
    C0013227 (Pharmaceutical Preparations)
    SNOMED
    763158003
    LOINC
    LP100609-9
    UMLS CUI [1,2]
    C0806020 (End date)
    SNOMED
    454551000124105
    LOINC
    MTHU008302
    Signature
    Description

    Signature

    Date
    Description

    Date

    Data type

    date

    Alias
    UMLS CUI-1
    C0011008 (Date in time)
    SNOMED
    410671006
    Name of Investigator
    Description

    Name of Investigator

    Data type

    text

    Alias
    UMLS CUI-1
    C2826892 (Investigator Name)
    Signature of investigator
    Description

    Signature of investigator

    Data type

    text

    Alias
    UMLS CUI-1
    C2346576 (Investigator Signature)

    Similar models

    Concomitant Medication AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    Concomitant Medication
    C2347852 (UMLS CUI-1)
    Item
    Point in time
    integer
    C1276413 (UMLS CUI [1,1])
    C2348792 (UMLS CUI [1,2])
    Code List
    Point in time
    CL Item
    Diagnostic (0)
    C0086143 (UMLS CUI-1)
    CL Item
    Induction I (1)
    C3179010 (UMLS CUI-1)
    CL Item
    Induction II (optional) (2)
    C3179010 (UMLS CUI-1)
    CL Item
    Consolid. I (3)
    C3179017 (UMLS CUI-1)
    CL Item
    Consolid. II (4)
    C3179017 (UMLS CUI-1)
    CL Item
    Consolid. III (5)
    C3179017 (UMLS CUI-1)
    CL Item
    Consolid. IV (6)
    C3179017 (UMLS CUI-1)
    CL Item
    Maintenance (7)
    C0481504 (UMLS CUI-1)
    Item
    If Maintenance: Month
    integer
    C0481504 (UMLS CUI [1,1])
    C0439231 (UMLS CUI [1,2])
    Code List
    If Maintenance: Month
    CL Item
    after 1 Month (1)
    C0439231 (UMLS CUI-1)
    C0205447 (UMLS CUI-2)
    CL Item
    after 2 Month (2)
    C0439231 (UMLS CUI-1)
    C0205448 (UMLS CUI-2)
    CL Item
    after 3 Month (3)
    C0439231 (UMLS CUI-1)
    C0205449 (UMLS CUI-2)
    CL Item
    after 4 Month (4)
    C0439231 (UMLS CUI-1)
    C0205450 (UMLS CUI-2)
    CL Item
    after 5 Month (5)
    C0439231 (UMLS CUI-1)
    C0205451 (UMLS CUI-2)
    CL Item
    after 6 Month (6)
    C0439231 (UMLS CUI-1)
    C0205452 (UMLS CUI-2)
    CL Item
    after 7 Month (7)
    C0439231 (UMLS CUI-1)
    C0205453 (UMLS CUI-2)
    CL Item
    after 8 Month (8)
    C0439231 (UMLS CUI-1)
    C0205454 (UMLS CUI-2)
    CL Item
    after 9 Month (9)
    C0439231 (UMLS CUI-1)
    C0205455 (UMLS CUI-2)
    CL Item
    after 10 Month (10)
    C0439231 (UMLS CUI-1)
    C0205456 (UMLS CUI-2)
    CL Item
    after 11 Month (11)
    C0439231 (UMLS CUI-1)
    C0205457 (UMLS CUI-2)
    CL Item
    after 12 Month (12)
    C0439231 (UMLS CUI-1)
    C0205458 (UMLS CUI-2)
    Pharmalogical Substance
    Item
    Pharmalogical Substance
    text
    C0013227 (UMLS CUI [1])
    Dose
    Item
    Dose
    integer
    C3174092 (UMLS CUI [1])
    Unit
    Item
    Unit
    text
    C0869039 (UMLS CUI-1)
    Item
    Application
    text
    C0185125 (UMLS CUI [1])
    Code List
    Application
    CL Item
    oral (1)
    C0442027 (UMLS CUI-1)
    CL Item
    intravenous (2)
    C0348016 (UMLS CUI-1)
    CL Item
    intramuscular (3)
    C0442117 (UMLS CUI-1)
    CL Item
    subcutaneous (4)
    C0443315 (UMLS CUI-1)
    CL Item
    sublingual (5)
    C0001565 (UMLS CUI-1)
    CL Item
    rectal (6)
    C0205052 (UMLS CUI-1)
    CL Item
    Inhalation (7)
    C0205535 (UMLS CUI-1)
    CL Item
    topical (8)
    C0332237 (UMLS CUI-1)
    CL Item
    other (9)
    C0205394 (UMLS CUI-1)
    Frequency
    Item
    Frequency
    text
    C3476109 (UMLS CUI [1])
    Medical indication
    Item
    Medical indication
    text
    C2315323 (UMLS CUI-1)
    Start Date of Medication
    Item
    Start Date of Medication
    date
    C0013227 (UMLS CUI [1,1])
    C0808070 (UMLS CUI [1,2])
    Stop Date
    Item
    Stop Date Medication
    date
    C0013227 (UMLS CUI [1,1])
    C0806020 (UMLS CUI [1,2])
    Item Group
    Signature
    Date
    Item
    Date
    date
    C0011008 (UMLS CUI-1)
    Name of Investigator
    Item
    Name of Investigator
    text
    C2826892 (UMLS CUI-1)
    Signature of investigator
    Item
    Signature of investigator
    text
    C2346576 (UMLS CUI-1)

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial